Wait...
Search Global Export Import Trade Data
Recent Searches: No Recent Searches

India exports 50 million hydroxychloroquine tablets to US for COVID-19 fight: Source.


Date: 01-05-2020
Subject: India exports 50 million hydroxychloroquine tablets to US for COVID-19 fight: Source
India has shipped 50 million tablets of hydroxychloroquine to the United States, an Indian source with direct knowledge of the exports said, although US regulators warned the anti-malarial drug may have harmful side effects in the treatment of COVID-19.

The trade, India's biggest export of the drug to any country, follows a request by US President Donald Trump for New Delhi to release supplies of hydroxychloroquine as a possible treatment for the respiratory disease.

"It amounts to 50 million tablets... Commercial companies are pursuing. It's ongoing," said the source, who declined to be identified due to the sensitivity of discussions with the United States.

The US Food and Drug Administration, the European Union's drug regulator and the Canadian health department have cautioned against the use of hydroxychloroquine, citing side effects such as abnormal heart rhythms and a dangerously rapid heart rate.

However, the health warnings have done little to deter the drug's imports to the United States, where some doctors are continuing to prescribe the drug for the treatment of COVID-19.

"There is high demand for hydroxychloroquine in the international market including US," Viranchi Shah, senior vice-president, Indian Drug Manufacturers Association (IDMA), told Reuters.

This month India said it would allow some exports of hydroxychloroquine after Trump touted it as a "game changer" and urged Prime Minister Narendra Modi to send supplies.

In Modi's home state of Gujarat, 68 new licences have been issued to drugmakers to manufacture hydroxychloroquine formulations, HG Koshia, commissioner, Food and Drug Control Administration (FDCA), Gujarat, told Reuters.

"Majority of these licences are for exports," he said.

Teva Pharmaceutical Industries, IPCA Laboratories and Cadila Healthcare are among India's leading suppliers of hydroxychloroquine.

Cadila Healthcare recently said it was ramping up production tenfold to 30 metric tonnes per month.

Sales of the decades-old treatment had soared overnight after Trump's advocacy of the drug, raising questions whether political pressure had overridden scientific criteria in the crisis.

As the US coronavirus death toll topped 60,000 on Wednesday - the highest in the world - doctors in the United States are desperate for anything that might alter the course of the disease, which attacks the lungs and can shut down other organs in severe cases.

"Pharma companies in Gujarat are continuing to produce and export hydroxychloroquine in large quantities," IDMA's Shah said.

The foreign ministry said India was continuing to supply hydroxychloroquine, and other essential medicines produced in India, to other countries. These supplies were taking place both on a humanitarian and a commercial basis.

Source:- moneycontrol.com

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Both
 Buyers
 Suppliers
 Both
OR
 Exim Help
+


What is New?

Date: 22-11-2023
Notification No. 13/2023 -Customs (ADD)
Seeks to further amend notification No. 47/2021-Customs (ADD), dated 26th August, 2021, imposing Anti-dumping Duty on imports of "Natural mica-based pearl industrial pigments excluding cosmetic grade" from China PR, to modify the existing duty table .

Date: 21-11-2023
NOTIFICATION No. 12/2023-Customs (ADD)
Seeks to continue levy of anti-dumping duty on "Synthetic Grade Zeolite 4A (Detergent Grade) from China PR for 5 years pursuant to First Sunset Review Final Findings issued by DGTR."

Date: 17-11-2023
NOTIFICATION No. 11/2023-Customs (ADD)
seeks to impose anti-dumping duty on toughened glass for home appliances imported from China PR for a period of 5 years.

Date: 17-11-2023
NOTIFICATION No. 54/2023- Central Tax
Seeks to amend Notification No. 27/2022 dated 26.12.2022 to notify biometric-based Aadhaar authentication for GST registration in the State of Andhra Pradesh.

Date: 16-11-2023
Notification No. 84/2023 - Customs (N.T.)
Exchange Rate Notification No. 84/2023-Cus (NT) dated 16.11.2023-reg

Date: 15-11-2023
Notification No. 83/2023 - Customs (N.T.)
Exchange Rate Notification No. 83/2023-Cus (NT) dated 15.11.2023-reg

Date: 15-11-2023
Notification No. 82/2023-CUSTOMS (N.T.)
Fixation of Tariff Value of Edible Oils, Brass Scrap, Areca Nut, Gold and Silver- Reg.

Date: 02-11-2023
Notification No. 16/2023- Union Territory Tax (Rate)
Seeks to amend Notification No 17/2017- Union territory Tax (Rate) dated 28.06.2017.

Date: 02-11-2023
NOTIFICATION No. 53/2023– CENTRAL TAX
Seeks to notify a special procedure for condonation of delay in filing of appeals against demand orders passed until 31st March, 2023.

Date: 02-11-2023
Notification No. 81/2023 - Customs (N.T.)
Exchange Rate Notification No. 81/2023-Cus (NT) dated 02.11.2023-reg



Exim Guru Copyright © 1999-2023 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.

EximGuru.com

C/o InfodriveIndia Pvt Ltd
F-19, Pocket F, Okhla Phase-I
Okhla Industrial Area
New Delhi - 110020, India
Phone : 011 - 40703001